You have to admire the "shorts." Only a deal, which could be...

You have to admire the "shorts." Only a deal, which could be non-dilutive, with the 2nd largest bio-pharma in the world means end times and bankruptcy for UNS. After they have to changed their projected UNS bankruptcy target date a few times you would think they might get a clue.

Pieces of the puzzle or the mosaic are coming together nicely. The next thing we await is the Orbimed induced management change. After that I would expect a corporate update as to where the ramps stand and managements strategic plan for moving forward. Then after that probably a couple new customer agreements.

Orbimed is going to walk UNS across the finish line. They stand to make BIG BANK off this deal.

UNS is going nowhere but forward.